Telehealth Start-Up Calibrate Raises $100 Million In Funding Round, Plans To Expand Weight Loss Platform

Calibrate, a telehealth start-up focused on metabolic health and weight loss, raised $100 million in a Series B funding round. The company plans to expand its weight loss platform. The round was co-led by new investors Founders Fund and Tiger Global. Optum Ventures also participated in the round, as did existing investors Forerunner Ventures, Threshold Ventures and Redesign Health.

The company launched operations in early 2020. It provides an entirely digital, holistic intensive lifestyle intervention combined with physician-prescribed GLP-1 medications, such as Wegovy. During its first year of operations, Calibrate members lost an average of 14 . . .